Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

19 October 2009

Prognostic significance of immunohistochemical Rac1 expression in survival in early operable non-small cell lung cancer

Kai YuanABCDEF, Chen QianAEFG, Ruheng ZhengAEG

Med Sci Monit 2009; 15(11): BR313-319 :: ID: 878233


The small GTPases are involved in the regulation of critical cellular functions, such as transcription control, cell cycle, and organization of actin cytoskeleton. Although a number of investigations have established the significance of Rho-family GTPases in several human tumors, there is still little information available on the clinical significance of Rac1 expression in non-small cell lung cancer (NSCLC). Therefore, immunohistologic expression of Rac1 was studied in a tissue microarray of 111 Stage I-II NSCLCs and correlated with clinicopathologic parameters and clinical outcome.
Material and Method
For this retrospective study 111 tissue samples, obtained from anonymized patients with early operable NSCLC (stage I-II), were used to construct a tissue microarray for immunohistochemical study.
Rac1 showed a cytoplasmic pattern of expression in tumor cells, while normal lung components showed negative or weak cytoplasmic staining. Rac1 expression increased significantly with the advancement of the T stage (P<0.01) and the TNM stage (P<0.05). Analysis of overall survival showed that Rac1 expression was related to poor outcome (P=0.012), even in the group of stage I patients (P=0.023). Multivariate analysis showed that Rac1 overexpression was an independent marker for overall survival after adjusting for other prognostic factors (P=0.023).
We found a positive prognostic value of immunohistologically determined Rac1 protein expression and presents Rac1 as a potential unfavorable prognosis biomarker in patients with early operable NSCLC.

Keywords: Proportional Hazards Models, Lung Neoplasms - surgery, Carcinoma, Non-Small-Cell Lung - surgery, rac1 GTP-Binding Protein - metabolism

Add Comment 0 Comments


01 July 2024 : Editorial  

Editorial: The Global Threats of Increasing Antimicrobial Resistance Require New Approaches to Drug Development, Including Molecular Antimicrobial Adjuvants

Dinah V. Parums

DOI: 10.12659/MSM.945583

Med Sci Monit 2024; 30:e945583


In Press

Clinical Research  

Cost-Effectiveness Analysis of Hepatic Arterial Chemotherapy for Advanced Hepatocellular Carcinoma in China...

Med Sci Monit In Press; DOI: 10.12659/MSM.944526  


Clinical Research  

Comparative Analysis of Antihypertensive and Anticonvulsant Regimens in Managing Pre-eclampsia and Eclampsi...

Med Sci Monit In Press; DOI: 10.12659/MSM.944985  

Clinical Research  

Reduced Radial Artery Occlusion in Transradial Cerebral Angiography: Key Predictive Factors and Preventive ...

Med Sci Monit In Press; DOI: 10.12659/MSM.944297  

Database Analysis  

Enhanced Outcomes in Femoral Subtrochanteric Fractures Using Long INTERTAN Nails with Titanium Cable Cercla...

Med Sci Monit In Press; DOI: 10.12659/MSM.944383  

Most Viewed Current Articles

17 Jan 2024 : Review article   4,116,598

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799


14 Dec 2022 : Clinical Research   1,594,331

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990


16 May 2023 : Clinical Research   691,000

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387


01 Jan 2022 : Editorial   50,822

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952


Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750